← Evidence map

TrialAnnals of hematology2021

Busulfan, etoposide, cytarabine, and melphalan as a high-dose regimen for autologous stem cell transplantation in peripheral T-cell lymphomas.

Jae-Cheol Jo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2021
2022
2023
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 33205337